International experiences with ofloxacin, a new quinolone S. Mitsuhashi Opening Remarks Pages: S223 - S225
Antibacterial activity of ofloxacin and its mode of action K. SatoY. InoueS. Mitsuhashi Originalia Pages: S226 - S230
The activity of ofloxacin against methicillin-resistant staphylococcus aureus Mirjana MraovićMirjana Čanić-Radojlović Originalia Pages: S231 - S232
Comparative activity of ofloxacin and seven other antimicrobials against urea-splitting microorganisms A. TorresR. Fernández-RoblasF. Soriano Originalia Pages: S233 - S236
Comparative in vitro antibacterial activity of ofloxacin and ciprofloxacin against some selected gram-positive and gram-negative isolates P. Y. ChauY. K. LeungW. W. S. Ng Originalia Pages: S237 - S239
Comparison of the in vitro activity of ofloxacin and gentamicin against isolates from hospitalised patients F. A. B. Adeyemi-DoroN. A. Rotowa Originalia Pages: S240 - S242
In vitro activity of ofloxacin against 210 clinical isolates of typhoid salmonellae A. Hannan Originalia Pages: S243 - S244
Investigations on ofloxacin: Antibacterial activity and influence on the immune system G. PulvererG. Peters Originalia Pages: S245 - S247
Assessment of immunomodulating activity of ofloxacin and three other quinolones in human plasma C. De SimoneV. VulloM. Grassi Originalia Pages: S248 - S249
Study of the cerebrospinal fluid penetrability of ofloxacin G. StübnerW. WeinrichU. Brands Originalia Pages: S250 - S253
Diffusion of ofloxacin into the cerebrospinal fluid in patients with bacterial meningitis J. P. StahlJ. P. BruJ. B. Fourtillan Originalia Pages: S254 - S255
Influence of ofloxacin on murine Peyer's patch lymphocytes De SimoneS. ZanzogluD. F. Sorice Originalia Pages: S256 - S257
Effects of quinolones on granulocyte function in vitro M. A. BoogaertsS. MalbrainR. L. Verwilghen Originalia Pages: S258 - S262
Diffusion of oral ofloxacin (HOE 280) into human prostatic tissue: Assessment by an improved high-performance liquid chromatographic method R. ClaesJ. C. DupontM. Podoor Originalia Pages: S263 - S265
Efficacy of ofloxacin (Hoe 280) in a model of subcutaneous abscess: Penetration and prevention of abscess formation Mercedes C. García IglesiasE. J. Perea Originalia Pages: S266 - S269
Further methdological improvement in antibiotic bone concentration measurements: Penetration of ofloxacin into bone and cartilage D. H. WittmannE. Kotthaus Originalia Pages: S270 - S273
Ofloxacin: Concentration in human ejaculate and influence on sperm motility P. Schramm Originalia Pages: S274 - S275
Tissue concentrations of ofloxacin in necrotic lesions in patients with peripheral vascular disease and in diabetics U. Müller-BühlC. DiehmF. Gutzler Originalia Pages: S276 - S278
Clinical evaluation of ofloxacin in lower respiratory tract infections H. Kobayashi Originalia Pages: S279 - S282
Ofloxacin in lower respiratory tract infections — a comparison with amoxicillin R. DevogelaereP. Maes Originalia Pages: S283 - S289
A double-blind randomized study comparing ofloxacin and amoxicillin in treating infective episodes in bronchiectasis W. K. LamP. Y. ChauM. K. Sham Originalia Pages: S290 - S292
Treatment of surgical infections with a modern quinolone: Therapy of soft tissue infections and pneumonia with ofloxacin T. FritzenE. MarxJ. Uy Originalia Pages: S293 - S296
Ofloxacin: Clinical evaluation in urinary and respiratory infections S. DeliaC. De SimoneF. Sorice Originalia Pages: S297 - S299
A multicenter study on clinical efficacy of ofloxacin in respiratory and urinary tract infections Giuliana Gialdroni Grassi Originalia Pages: S300 - S302
Clinical experience with ofloxacin in urinary tract infection Clair E. CoxSusan V. CalleryK. J. Tack Preliminary Study Pages: S303 - S304
Clinical evaluation of ofloxacin versus ciprofloxacin in complicated urinary tract infections B. Kromann-AndersenP. SommerV. Larsen Originalia Pages: S305 - S306
Clinical experience with ofloxacin (DL 8280) in the therapy of various infections: Preliminary report P. CristianoV. LeonessaP. Altucci Preliminary Results Pages: S307 - S308
Clinical experience with ofloxacin in sexually transmitted disease F. N. JudsonBarbara S. BealsK. J. Tack Originalia Pages: S309 - S310
Efficacy of ofloxacin in uncomplicated gonorrhoea C. AriyaritK. PanikabutraA. Buatiang Originalia Pages: S311 - S313
Single dose ofloxacin in treatment of uncomplicated gonorrhoea A. S. C. ChanW. K. C. TangT. K. Ng Originalia Pages: S314 - S315
Ofloxacin: Therapeutic results in chlamydia trachomatis urethritis W. Bischoff Originalia Pages: S316 - S317
Treatment of genital chlamydial infection with ofloxacin L. FransenD. AvontsP. Piot Originalia Pages: S318 - S320
Ofloxacin, a new quinolone in the treatment of genitourinary and enteric infections D. TanphaichitraS. SahaphongS. Srimuang Originalia Pages: S321 - S323
Ofloxacin in oral chemotherapy of acute and chronic otitis media T. Lenarz Originalia Pages: S324 - S326
Clinical efficacy of ofloxacin in the treatment of otorhinolaryngological infections S. Baba Originalia Pages: S327 - S331
Safety of ofloxacin — adverse drug reactions reported during phase-II studies in europe and in Japan R. BlomerK. BruchW. Wacheck Originalia Pages: S332 - S334
Safety profile of ofloxacin: The Italian data base A. KoverechM. PicariG. Recchia Originalia Pages: S335 - S337